Comment on “Phase I Randomized, Placebo-Controlled, Cross-Over Dose-Finding Study of Coenzyme Q 10 on Doxorubicin Pharmacokinetics During Breast Cancer Treatment”

Integrative Cancer Therapies · Published 2026-01-01 · DOI 10.1177/15347354251414639

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/15347354251414639

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Cytotoxic Potential and Metabolomic Profiling of Solanum lycopersicum Roots Extract and Their Nanocrystals: An In Silico Approach · Integrative Cancer Therapies · 2025 · Same journal
• A Promising Natural Red Pigment “Prodigiosin” Sensitizes Colon Cancer Cells to Ionizing Radiation, Induces Apoptosis, and Impedes MAPK/TNF-α/NLRP3 Signaling Pathway · Integrative Cancer Therapies · 2025 · Same journal
• Pharmacodynamics of huaier aqueous extract against papillary thyroid carcinoma in vivo and in vitro · Integrative Cancer Therapies · 2025 · Same journal
• Reporting Quality of Randomized Controlled Trials Published in Integrative Cancer Therapies : Evaluation Against CONSORT 2010 and Perspectives for CONSORT 2025 · Integrative Cancer Therapies · 2026 · Same journal
• Deepening the Framework: A TCM-Informed Perspective on Qualitative Experiences in Integrative Psycho-Oncology for Colorectal Cancer Survivors · Integrative Cancer Therapies · 2026 · Same journal
• Diet Habits, Smoking, and Alcohol Consumption Among Chinese Patients with Cancer · Integrative Cancer Therapies · 2025 · Same journal
• Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial · Integrative Cancer Therapies · 2025 · Same journal
• Chinese Herbal Medicine for Concurrent Chemoradiation-Induced Adverse Events in Head and Neck Cancer Patients: A Prospective Feasibility Study · Integrative Cancer Therapies · 2025 · Same journal
• Impact of Sodium Ascorbate High Dose on Quality of Life and Pain in Patients Diagnosed With and Treated for Terminal Cancer (Real-World Data Study) · Integrative Cancer Therapies · 2026 · Same journal
• Phase 1 Trial of Withania somnifera Leaf Extract (RH324) in Advanced Non-Small Cell Lung Cancer Including [ 18 F]FDG PET/CT as a Short-Term Metabolic Biomarker to Assess Efficacy: A Novel Model for Assessment of Complimentary Therapies in Early Phase Human Clinical Trials · Integrative Cancer Therapies · 2026 · Same journal